2137 Comparison of two Phase II trials of mFOLFOX6 plus...

2137 Comparison of two Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver only metastases

Oki, E., Emi, Y., Miyamoto, Y., Ogata, Y., Tokunaga, S., Shirabe, K., Beppu, T., Uchida, S., Takatsuki, M., Sakoda, M., Eguchi, S., Akagi, Y., Kakeji, Y., Baba, H., Natsugoe, S., Maehara, Y.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31058-9
Date:
September, 2015
File:
PDF, 63 KB
english, 2015
Conversion to is in progress
Conversion to is failed